Two days after being taken to hospital Malcolm, a dad-of-four and who was "worshipped" by his three step-children, was ...

Lauren Williams, 74, is trying to raise awareness about the dangers of experimental trials after her husband Malcolm, a ...

For patients with advanced renal cell carcinoma (RCC), there is a sustained clinical benefit with pembrolizumab plus axitinib ...

A man who 'jumped at the opportunity' to take part in a miracle drug trial died with days of starting the treatment, says his ...

A leading scientist, a businesswoman and a disease-free patient come together to tell the full story of the promising ...

CytomX Therapeutics' innovative cancer therapies show promise with the CX-2051 and CX-801 trials. Explore the potential of ...

A new treatment for advanced endometrial cancer has been approved for use on the NHS, after women with the disease were found ...

Eftilagimod alfa shows promise as a novel immunotherapy for head and neck cancer patients with low PD-L1 expression, offering ...

A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published in Nature Medicine.

A study reveals real-world outcomes of neoadjuvant immune checkpoint inhibitors in nonmetastatic colon cancer, highlighting ...

Adverse events reported in oncology clinical trials don’t always match what patients experience. What is behind this ...

Thousands of women with endometrial cancer are set to benefit from new immunotherapy treatment that has been approved by the UK medicine watchdog. From 6 August healthcare professionals can use ...